Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2680 of 5804
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control CompletedA Phase I/Ib, First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of DF6215 Monotherapy and in Combination Therapy in Patients with Advanced (Unresectable, Recurrent, or Metastatic) Solid Tumors;…
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to get more heart patients into rehab
Disease control OngoingThe goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Why do stem cell survivors feel exhausted? new study digs into brain inflammation.
Knowledge-focused Recruiting nowPatients undergoing allogenic stem cell transplantation are regularly followed up in the outpatient clinic at Karolinska University Hospital. Here, patients are offered participation the fatigue study measuring both fatigue and cognitive impairment systematically by international…
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:15 UTC
-
Can music and mindfulness ease the toll of stem cell transplants?
Symptom relief OngoingThe goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burden of patients undergoing allogeneic stem cell transplantation (allo-SCT).
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Can better sleep ease Crohn's symptoms? new study investigates
Symptom relief OngoingThe purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New screening tool aims to catch lung disease early in arthritis patients
Knowledge-focused CompletedThe overall aim of the study is to develop and validate a Rheumatoid Arthritis-Interstitial Lung Disease (RA-ILD) clinical prediction model (screening tool) based on risk factors to guide screening for ILD in patients with RA using High Resolution Computed Tomography (HRCT).
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Diet and exercise program tested in men with advanced prostate cancer
Disease control Recruiting nowThe proposed pilot study aims at determining the feasibility of a lifestyle intervention including adherence to a personalised dietary regimen combined with regular physical activity in patients newly diagnosed with prostate cancer under androgen deprivation therapy.
Phase: NA • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can we unlabel 'Allergic' kids in the ER? new study says maybe
Symptom relief OngoingBeta-lactams are the most common antibiotics prescribed to children, including penicillin and amoxicillin. They are usually more effective and have fewer side effects than other ty antibiotics. Some children can have reactions to these antibiotics that can be mistaken as an aller…
Phase: PHASE1 • Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New CPAP strategy aims to help preterm lungs grow stronger
Disease control Recruiting nowPreterm neonates born at less than 30 weeks' gestation are commonly maintained on invasive or non-invasive respiratory support to facilitate gas exchange. While non-invasive respiratory support (NIS) can be gradually reduced over time as the infant grows, most weaning strategies …
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Automated calls help cancer patients kick the habit
Disease control CompletedThis is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combinatio…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Magic mushroom compound may rebuild brain synapses in early memory loss
Knowledge-focused OngoingThe goal of this pilot, exploratory, clinical trial is to investigate the effects of psilocybin on synaptic vesicular density (SVD) as measured by the positron emission tomography (PET) radiotracer, 18F-SynVesT-1, in participants with amnestic Mild Cognitive Impairment (aMCI) and…
Phase: PHASE2 • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Timing of MS drug may change disease course
Disease control Recruiting nowThis non-interventional study will compare the effect of Ofatumumab treatment between patients that began Ofatumumab within the 3 years after Multiple Sclerosis diagnosis and patients that began Ofatumumab with more than 3 years of Multiple Sclerosis diagnosis in a real-world set…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New supplement trial aims to fight chemo fatigue in breast cancer patients
Symptom relief Recruiting nowThe goal of this clinical trial is to test the effect of the administration of APPORTAL® in addition to the SoC (recommended physical exercise), in patients with breast cancer, suffering from fatigue during neoadjuvant and adjuvant chemotherapy. The main questions it aims to answ…
Phase: NA • Sponsor: Pharmanutra S.p.a. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New cancer drug combo enters first human tests
Disease control Recruiting nowThis is a first-in-human Phase I, open-label, dose-escalation and expansion study designed to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamic, and preliminary anti-tumor activity of RO7566802 as a single agent and in combination with atezolizu…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Nasal spray shows promise for tough asthma in early trial
Disease control CompletedThis clinical trial aims to investigate patients with poorly controlled, moderate to severe eosinophilic asthma. The main questions it seeks to answer are 1. Could the AD17002 intranasal immunomodulator improve the clinical condition of eosinophilic asthmatic patients? 2. Could …
Phase: PHASE1, PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:35 UTC
-
Liver cancer patients: which drug works best after immunotherapy?
Knowledge-focused OngoingThis is an observational study in which only data will be collected from adults with unresectable hepatocellular carcinoma. These adults should be prescribed a different treatment after treatment with atezolizumab and bevacizumab, or another similar combination of drugs, by their…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New app aims to keep pregnancy weight gain in check
Disease control Recruiting nowThe goal of this clinical trial is to see if the enhanced HMZ 2.0 intervention with new control system/digital platform to regulate gestational weight gain (GWG) and impact maternal-infant outcomes while collecting implementation data works and can be given to other pregnant wome…
Phase: NA • Sponsor: Penn State University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for vitiligo: experimental drug aims to restore skin color
Disease control TerminatedResearchers are looking for a new way to treat people with non-segmental vitiligo (NSV). The goal of this study is to learn about the safety of MK-6194 and how well people tolerate it. Researchers also want to learn if people who take MK-6194 have more of a decrease in the amount…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for advanced cancer: experimental drug DR30206 enters human testing
Disease control Recruiting nowThis study is to characterize the safety,tolerability, pharmacokinetics(PK),and preliminary anti-tumor activity of DR30206, in subjects with advanced or metastatic solid tumors
Phase: PHASE1 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study: could a 30-Minute procedure end heavy periods for good?
Symptom relief Recruiting nowHeavy menstrual bleeding (HMB) affects 30% of women worldwide. It negatively influences physical activity, work productivity, sexual life and overall quality of life. In 2018, the FIGO (International Federation of Gynaecology and Obstetrics) revised its definition of AUB (FIGO-A…
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC